When positive studies of novel therapies are subsequently nullified: Cumulative meta-analyses in preeclampsia

Clinical and Investigative Medicine

Volumn 38, Issue 5, 2015, Pages E274-E283

  Etwel, Fatma ^a   Koren, Gideon ^a,b  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIOXIDANT;

DOUBLE BLIND PROCEDURE; FEMALE; FETAL GROWTH RETARDATION; HUMAN; JOURNAL IMPACT FACTOR; META ANALYSIS; ODDS RATIO; PRE-ECLAMPSIA; PREGNANCY; STANDARDS; THERAPY;

ANTIOXIDANTS; ASPIRIN; DOUBLE-BLIND METHOD; FEMALE; FETAL GROWTH RETARDATION; HUMANS; JOURNAL IMPACT FACTOR; ODDS RATIO; PRE-ECLAMPSIA; PREGNANCY; THERAPEUTICS;

EID: 84944459502     PISSN: 0147958X     EISSN: 14882353     Source Type: Journal    
DOI: 10.25011/cim.v38i5.25684     Document Type: Article

References (49)

1. Koren G. Treating the mother, protecting the unborn: the motherisk approach. PediatrPharmacolTer. 2013 Jan;18(1):4-7. doi: 10.5863/1551-6776-18.1.4.
2. Lyerly AD, FadenRR. Mothers Matter: Ethics and Research during Pregnancy. Virtual Mentor. 2013 Sep 1;15(9):775-8
3. Kianifar H, Sadeghi R, Zarifmahmoudi L. Comparison Between Impact Factor, Eigenfactor Metrics, and SCimago Journal Rank Indicator of Pediatric Neurology Journals. Acta Inform Med. 2014 Apr;22(2):103-6.
4. Gordin D, Forsblom C, Groop PH, Teramo K, Kaaja R. Risk factors of hypertensive pregnancies in women with diabetes and the influence on their future life. Ann Med. 2014 Jul 21:1-5.
5. Salles AM, Galvao TF, Silva MT, Motta LC, Pereira MG. Antioxidants for preventing preeclampsia: a systematic review. ScientificWorldJournal. 2012;2012:243476. doi: 10.1100/2012/243476. Epub 2012 Apr 19.
6. Henderson JT, Whitlock EP, O'Connor E, Senger CA, Tompson JH, Rowland MG. Low-dose aspirin for prevention of morbidity and mortality from preeclampsia: a systematic evidence review for the U.S. Preventive Services Task Force. Ann Intern Med. 2014 May 20;160(10):695-703.
7. Shea BJ, Grimshaw JM, Wells GA, Boers M, Andersson N, Hamel C, Porter AC, Tugwell P, Moher D, Bouter LM. Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol. 2007 Feb 15;7:10.
8. Sequeira-Byron P, Fedorowicz Z, Jagannath VA, Sharif MO. An AMSTAR assessment of the methodological quality of systematic reviews of oral healthcare interventions published in the Journal of Applied Oral Science (JAOS). J Appl Oral Sci. 2011 Oct;19(5):440-7.
9. Higgins JP, Tompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003; 327(7414):557-60.
10. J. Higgins and S. Green, Eds., Cochrane Handbook for Systematic Reviews of Interventions, Version 5.1.0 edition, 2011, http://www.cochrane-handbook.org.
11. Royle P, Kandala NB, Barnard K, Waugh NSyst Rev. Bibliometrics of systematic reviews: analysis of citation rates and journal impact factors. Sys Rev.2013 Sep 12;2:74. doi: 10.1186/2046-4053-2-74.
12. Koren G. Bias against the null hypothesis in maternal-fetal pharmacology and toxicology. ClinPharmacolTer. 1997 Jul;62(1):1-5.
13. Koren G, Graham K, Shear H, Einarson T. Bias against the null hypothesis: the reproductive hazards of cocaine. Lancet. 1989 Dec 16;2(8677):1440-2.
14. Easterbrook PJ, Berlin JA, Gopalan R, Matthews DR. Publication bias in clinical research. Lancet. 1991 Apr 13;337(8746):867-72.
15. Jannot AS, Agoritsas T, Gayet-Ageron A, Perneger TV. Citation bias favoring statistically significant studies was present in medical research. J ClinEpidemiol. 2013 Mar;66(3):296-301. doi: 10.1016/j.jclinepi.2012.09.015.
16. Koren G, Klein N. Bias against negative studies in newspaper reports of medical research. JAMA. 1991 Oct 2;266(13):1824-6.
17. Koren G, Nickel C. Perpetuating fears: bias against the null hypothesis in fetal safety of drugs as expressed in scientific citations. J PopulTerClinPharmacol. 2011;18(1):e28-32.
18. Kodumuri P, Ollivere B, Holley J, Moran CG. Te impact factor of a journal is a poor measure of the clinical relevance of its papers. Bone Joint J. 2014 Mar;96-B(3):414-9.
19. Lau J, Antman EM, Jimenez-Silva J, Kupelnick B, Mosteller F, Chalmers TC. Cumulative meta-analysis of therapeutic trials for myocardial infarction. N Engl J Med. 1992 Jul 23;327(4):248-54.
20. Han L, Zhou SM. Selenium supplement in the prevention of pregnancy induced hypertension. Chin Med J (Engl). 1994 Nov;107(11):870-1.
21. Chappell LC, Seed PT, Briley AL, Kelly FJ, Lee R, Hunt BJ, Parmar K, Bewley SJ, Shennan AH, Steer PJ, Poston L. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial. Lancet. 1999 Sep 4;354(9181):810-6.
22. Sharma JB, Kumar A, Kumar A, Malhotra M, Arora R, Prasad S, Batra S. Effect of lycopene on pre-eclampsia and intra-uterine growth retardation in primigravidas. Int J Gynaecol Obstet. 2003 Jun;81(3):257-62.
23. Steyn PS, Odendaal HJ, Schoeman J, Stander C, Fanie N, Grové D. A randomised, double-blind placebo-controlled trial of ascorbic acid supplementation for the prevention of preterm labour. J ObstetGynaecol. 2003 Mar;23(2):150-5.
24. Beazley D, Ahokas R, Livingston J, Griggs M, Sibai BM. Vitamin C and E supplementation in women at high risk for preeclampsia: a double-blind, placebo controlled trial. Am J Obstet Gynecol. 2005 Feb;192(2):520-1.
25. Poston L, Briley AL, Seed PT, Kelly FJ, Shennan AH; Vitamins in Pre-eclampsia (VIP) Trial Consortium. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet. 2006 Apr 8;367(9517):1145-54.
26. Rumbold AR, Crowther CA, Haslam RR, Dekker GA, Robinson JS; ACTS Study Group. Vitamins C and E and the risks of preeclampsia and perinatal complications. N Engl J Med. 2006 Apr 27;354(17):1796-806.
27. Rumiris D, Purwosunu Y, Wibowo N, Farina A, Sekizawa A. Lower rate of preeclampsia afer antioxidant supplementation in pregnant women with low antioxidant status. Hypertens Pregnancy. 2006;25(3):241-53.
28. Spinnato JA 2nd, Freire S, Pinto E, Silva JL, Cunha Rudge MV, Martins-Costa S, Koch MA, Goco N, Santos Cde B, Cecatti JG, Costa R, Ramos JG, Moss N, Sibai BM. Antioxidant therapy toprevent preeclampsia: a randomized controlled trial. Obstet Gynecol. 2007 Dec;110(6):1311-8.
29. Banerjee S, Jeyaseelan S, Guleria R. Trial of lycopene to prevent pre-eclampsia in healthy primigravidas: results show some adverse effects. J ObstetGynaecol Res. 2009 Jun;35(3):477-82.
30. Villar J, Purwar M, Merialdi M, Zavaleta N, TiNhu Ngoc N, Anthony J, De GreeffA, Poston L, Shennan A; WHO Vitamin C and Vitamin E trial group. World Health Organisationmulticentre randomised trial of supplementation with vitamins C and E among pregnant women at high risk for pre-eclampsia in populations of low nutritional status from developing countries. BJOG. 2009 May;116(6):780-8. doi: 10.1111/j.1471-0528.2009.02158.x.
31. McCance DR, Holmes VA, Maresh MJ, Patterson CC, Walker JD, Pearson DW, Young IS; Diabetes and Pre-eclampsia Intervention Trial (DAPIT) Study Group. Vitamins C and E for prevention of pre-eclampsia in women with type 1 diabetes (DAPIT): a randomised placebo-controlled trial. Lancet. 2010 Jul 24;376(9737):259-66.
32. Roberts JM, Myatt L, Spong CY, Tom EA, Hauth JC, Leveno KJ, Pearson GD, Wapner RJ, Varner MW, Torp JM Jr, Mercer BM, Peaceman AM, Ramin SM, Carpenter MW, Samuels P, Sciscione A, Harper M, Smith WJ, Saade G, Sorokin Y, Anderson GB; Eunice Kennedy Shriver National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Vitamins C and E to prevent complications of pregnancy-associated hypertension. N Engl J Med. 2010 Apr 8;362(14):1282-91.
33. Xu H, Perez-Cuevas R, Xiong X, Reyes H, Roy C, Julien P, Smith G, von Dadelszen P, Leduc L, Audibert F, Moutquin JM, Piedboeuf B, Shatenstein B, Parra-Cabrera S, Choquette P, Winsor S, Wood S, Benjamin A, Walker M, Helewa M, Dubé J, Tawagi G, Seaward G, Ohlsson A, Magee LA, Olatunbosun F, Gratton R, Shear R, Demianczuk N, Collet JP, Wei S, Fraser WD; INTAPP study group. An international trial of antioxidants in the prevention of preeclampsia (INTAPP).Am J Obstet Gynecol. 2010 Mar;202(3):239.e1-239.
34. Vadillo-Ortega F, Perichart-Perera O, Espino S, Avila-Vergara MA, Ibarra I, Ahued R, Godines M, Parry S, Macones G, Strauss JF. Effect of supplementation during pregnancy with L-arginine and antioxidant vitamins in medical food on pre-eclampsia in high risk population: randomised controlled trial. BMJ. 2011 May 19;342:d2901. doi: 10.1136/bmj.d2901.
35. Wallenburg HC, Dekker GA, Makovitz JW, Rotmans P. Lowdose aspirin prevents pregnancy-induced hypertension and preeclampsia in angiotensin-sensitive primigravidae. Lancet. 1986 Jan 4;1(8471):1-3.
36. Benigni A1, Gregorini G, Frusca T, Chiabrando C, Ballerini S, Valcamonico A, Orisio S, Piccinelli A, Pinciroli V, Fanelli R, et al. Effect of low-dose aspirin on fetal and maternal generation of thromboxane by platelets in women at risk for pregnancyinduced hypertension. N Engl J Med. 1989 Aug 10;321(6):357-62.
37. SchiffE, Peleg E, Goldenberg M, Rosenthal T, Ruppin E, Tamarkin M, Barkai G, Ben-Baruch G, Yahal I, Blankstein J, et al. Te use of aspirin to prevent pregnancy-induced hypertension and lower the ratio of thromboxane A2 to prostacyclin in relatively high risk pregnancies. N Engl J Med. 1989 Aug 10;321(6):351-6.
38. McParland P, Pearce JM, Chamberlain GV. Doppler ultrasound and aspirin in recognition and prevention of pregnancy-induced hypertension. Lancet. 1990 Jun 30;335(8705):1552-5.
39. Viinikka L1, Hartikainen-Sorri AL, Lumme R, Hiilesmaa V, Ylikorkala O. Low dose aspirin in hypertensive pregnant women: effect on pregnancy outcome and prostacyclinthromboxane balance in mother and newborn. Br J ObstetGynaecol. 1993 Sep;100(9):809-15.
40. Caspi E1, Raziel A, Sherman D, Arieli S, Bukovski I, Weinraub Z. Prevention of pregnancy-induced hypertension in twins by early administration of low-dose aspirin: a preliminary report. Am J ReprodImmunol. 1994 Jan;31(1):19-24.
41. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. Lancet. 1994 Mar 12;343(8898):619-29.
42. Hermida RC, Ayala DE, Iglesias M, Mojón A, Silva I, Ucieda R, Fernández JR. Time-dependent effects of low-dose aspirin administration on blood pressure in pregnant women. Hypertension. 1997 Sep;30(3 Pt 2):589-95.
43. Gallery ED, Ross MR, Hawkins M, et al. Low-dose aspirin in high-risk pregnancy? Hypertension Pregnancy. 1997;16(2):229-38.
44. Caritis S, Sibai B, Hauth J, Lindheimer MD, KlebanoffM, Tom E, VanDorsten P, Landon M, Paul R, Miodovnik M, Meis P, Turnau G. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med. 1998 Mar 12;338(11):701-5.
45. Grab D, Paulus WE, Erdmann M, Terinde R, Oberhoffer R, Lang D, Muche R, Kreienberg R. Effects of low-dose aspirin on uterine and fetal blood flow during pregnancy: results of a randomized, placebo-controlled, double-blind trial. Ultrasound Obstet Gynecol. 2000 Jan;15(1):19-27.
46. Vainio M, Kujansuu E, Iso-Mustajärvi M, Mäenpää J. Low dose acetylsalicylic acid in prevention of pregnancy-induced hypertension and intrauterine growth retardation in women with bilateral uterine artery notches. BJOG. 2002 Feb;109(2):161-7.
47. Yu CK1, Papageorghiou AT, Parra M, Palma Dias R, Nicolaides KH; Fetal Medicine Foundation Second Trimester Screening Group. Randomized controlled trial using low-dose aspirin in the prevention of pre-eclampsia in women with abnormal uterine artery Doppler at 23 weeks' gestation. Ultrasound Obstet Gynecol. 2003 Sep;22(3):233-9.
48. Villa PM, Kajantie E, Räikkönen K, Pesonen AK, Hämäläinen E, Vainio M, Taipale P, Laivuori H; PREDO Study group. Aspirin in the prevention of pre-eclampsia in high-risk women: a randomised placebo-controlled PREDO Trial and a metaanalysis of randomised trials. BJOG. 2013 Jan;120(1):64-74.
49. Ayala DE1, Ucieda R, Hermida RC. Chronotherapy with lowdose aspirin for prevention of complications in pregnancy. Chronobiol Int. 2013 Mar;30(1-2):260-79. doi: 10.3109/07420528.2012.717455. Epub 2012 Sep 24.